Physician profile
Tempest Varner
NPI 1932620580
$902.28
in general payments reported to CMS, 2019-2025
18 companies · $205 in 2025
The $205 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $12.60 · 2023: $65.73 · 2024: $497 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $767.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $767.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $230.61 | 2023-2025 | Trelegy Ellipta, Nucala |
| Astrazeneca Pharmaceuticals Lp | $181.00 | 2023-2025 | Airsupra, Tezspire |
| Takeda Pharmaceuticals U.S.A., INC. | $94.20 | 2024-2025 | Glassia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $88.78 | 2019-2024 | Ofev |
| Baxter Healthcare | $59.72 | 2024-2025 | Hillrom - Vest System Model 105 Home Care |
| Mallinckrodt Enterprises LLC | $28.83 | 2019 | |
| Shire North American Group INC | $28.09 | 2019 | |
| Resmed Corp | $22.50 | 2024 | |
| Pfizer INC. | $21.90 | 2024 | |
| Verona Pharma, INC. | $20.85 | 2025 | Ohtuvayre |
| Philips North America LLC | $19.62 | 2024 | (Ak6) Vest Therapy |
| Mylan Specialty L.P. | $17.50 | 2019 | |
| Ekos Corporation | $16.40 | 2019 | |
| Abbvie INC. | $15.74 | 2025 | |
| United Therapeutics Corporation | $15.45 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avadel Cns Pharmaceuticals, LLC | $15.01 | 2024 | Lumryz |
| Jazz Pharmaceuticals INC. | $13.48 | 2024 | |
| Mallinckrodt Hospital Products INC. | $12.60 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tempest Varner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.